AWM
AMPE

Avior Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Avior Wealth Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15
Closed -$18K – 831
2017
Q4 		$18K Buy
+15
New +$7.05K ﹤0.01% 556

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Avior Wealth Management's AMPE Position: Q1 2018 in Review

Avior Wealth Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2018, closing a stake of 15 shares — an estimated $18K sold.

Avior Wealth Management first reported a position in AMPE in Q4 2017 and held it in 1 quarter. The position peaked at $18K in Q4 2017. 71 funds tracked by Wall St. Rank hold AMPE as of Q1 2018.

  • Avior Wealth Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2018 after selling out during the quarter.
  • Avior Wealth Management sold 15 Ampio Pharmaceuticals Inc. shares in Q1 2018, an estimated $18K.
  • Avior Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2017 and held it in 1 quarter.
  • Avior Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $18K in Q4 2017.
  • 71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2018.

Based on Avior Wealth Management's 13F filing for Q1 2018, filed 15 May 2018.